Showing 1 - 10 of 102
Polish specificity (Kraft Foods/ Cadbury), approved subject to divestiture of the E. Wedel brand. …
Persistent link: https://www.econbiz.de/10011260409
Persistent link: https://www.econbiz.de/10008520728
our sample. We show how diffusion of generics is linked to the characteristics of the market and investigate how price … distinction seems to emerge. On the one hand, systems that rely on market-based competition in pharmaceuticals promote a clear … enjoy premium prices and exclusivity profits under patent protection, and face fierce price competition after patent expiry …
Persistent link: https://www.econbiz.de/10005034975
, and the activities of Shaman Pharmaceuticals in Latin America and Africa. It provides the details, discusses what each …
Persistent link: https://www.econbiz.de/10005621738
Within the debate about the rise of costs in the German health system, the argument has put forth that patients' excessive demand for benefits is caused by the existence of a moral hazard problem. One way of influencing an insured person's consumer behaviour is the introduction of several...
Persistent link: https://www.econbiz.de/10008765092
monopolistic manufacturer of pharmaceuticals and a foreign exclusive distributor we, first, show that parallel trade reduces the …
Persistent link: https://www.econbiz.de/10011107968
. Foreign-owned firms tend to be large, and thus the decisive share of BERD is performed by large enterprises. Pharmaceuticals … past fifteen years as foreign pharmaceuticals firms became majority owners in most companies, pursuing global R …
Persistent link: https://www.econbiz.de/10011113727
expenditure is of course influenced by policy and also by problems and inefficiencies on the market for pharmaceuticals production …
Persistent link: https://www.econbiz.de/10011114476
We consider a policy game between a high-income country hosting a drug innovator and a low-income country hosting a drug imitator. The low-income country chooses whether to enforce an International Patent Regime (strict IPR) or not (weak IPR) and the high-income country chooses whether to allow...
Persistent link: https://www.econbiz.de/10011115487
We analyze the influence of technological progress on pharmaceuticals on rising health expenditures using US State …
Persistent link: https://www.econbiz.de/10005790100